Y0001015
Norfloxacin for system suitability
European Pharmacopoeia (EP) Reference Standard
Manufacturer: Sigma Aldrich
CAS Number: 70458-96-7
Synonym(S): Norfloxacin, 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid, 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-piperazino-3-quinolinecarboxylic acid
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 10 MG | Y0001015-10-MG | In Stock | ₹ 14,629.80 |
Y0001015 - 10 MG
In Stock
Quantity
1
Base Price: ₹ 14,629.80
GST (18%): ₹ 2,633.364
Total Price: ₹ 17,263.164
grade
pharmaceutical primary standard
API family
norfloxacin
manufacturer/tradename
EDQM
application(s)
pharmaceutical (small molecule)
format
neat
storage temp.
2-8°C
SMILES string
CCN1C=C(C(O)=O)C(=O)c2cc(F)c(cc12)N3CCNCC3
InChI
1S/C16H18FN3O3/c1-2-19-9-11(16(22)23)15(21)10-7-12(17)14(8-13(10)19)20-5-3-18-4-6-20/h7-9,18H,2-6H2,1H3,(H,22,23)
InChI key
OGJPXUAPXNRGGI-UHFFFAOYSA-N
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
Norfloxacin Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™ | -- | ₹ 20,114.00 | ||
VETRANAL™ Norfloxacin, MilliporeSigma™ Supelco™ | -- | ₹ 15,753.00 | ||
Chem-Impex International, Inc. Norfloxacin | 70458-96-7 | MFCD00079532 | 5G | -- | ₹ 4,094.89 | ||
Norfloxacin | -- | ₹ 17,538.00 | ||
Norfloxacin | -- | ₹ 41,791.50 | ||
Norfloxacin | -- | ₹ 14,629.80 | ||
Norfloxacin | -- | ₹ 21,323.10 | ||
Norfloxacin | -- | ₹ 4,390.00 - ₹ 10,600.50 | ||
70458-96-7 | Norfloxacin | -- | ₹ 1,602.00 - ₹ 18,601.00 |
Related Products
Description
- General description: This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
- Application: Norfloxacin for system suitability EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.
- Biochem/physiol Actions: Norfloxacin blocks DNA replication by interfering with an ATP-induced structural transition of DNA complexed with DNA gyrase (topoisomerase).Mode of action: inhibits bacterial DNA replicationAntimicrobial spectrum: Gram-negative bacteria; less effective against Gram-positive bacteria
- Packaging: The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
- Other Notes: Sales restrictions may apply.
SAFETY INFORMATION
WGK
WGK 2
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable